V019-3602 Screening compound: 2-[(cyclopropylmethyl)[(propan-2-yl)carbamoyl]amino]-N-[1-(3-fluoro-4-methylphenyl)-4-phenyl-1H-imidazol-2-yl]acetamide

V019-3602 Screening compound: 2-[(cyclopropylmethyl)[(propan-2-yl)carbamoyl]amino]-N-[1-(3-fluoro-4-methylphenyl)-4-phenyl-1H-imidazol-2-yl]acetamide
V019-3602 Screening compound: 2-[(cyclopropylmethyl)[(propan-2-yl)carbamoyl]amino]-N-[1-(3-fluoro-4-methylphenyl)-4-phenyl-1H-imidazol-2-yl]acetamide alternative view

Chemical Structure Depiction of ChemDiv screening compound V019-3602
2-[(cyclopropylmethyl)[(propan-2-yl)carbamoyl]amino]-N-[1-(3-fluoro-4-methylphenyl)-4-phenyl-1H-imidazol-2-yl]acetamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V019-3602

Molecular Formula

C26H30FN5O2 (C26 H30 FN5 O2)

Compound Name

2-[(cyclopropylmethyl)[(propan-2-yl)carbamoyl]amino]-N-[1-(3-fluoro-4-methylphenyl)-4-phenyl-1H-imidazol-2-yl]acetamide

IUPAC name

2-[(cyclopropylmethyl)[(propan-2-yl)carbamoyl]amino]-N-[1-(3-fluoro-4-methylphenyl)-4-phenyl-1H-imidazol-2-yl]acetamide

SMILES

CC(C)NC(N(CC1CC1)CC(Nc1nc(-c2ccccc2)cn1-c1cc(F)c(C)cc1)=O)=O

InChI

InChI=1S/C26H30FN5O2/c1-17(2)28-26(34)31(14-19-10-11-19)16-24(33)30-25-29-23(20-7-5-4-6-8-20)15-32(25)21-12-9-18(3)22(27)13-21/h4-9,12-13,15,17,19H,10-11,14,16H2,1-3H3,(H,28,34)(H,29,30,33)

InChI Key

XMFOXGUCTQKNBS-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD19821878

Chemical and Physical Properties

Saltdata

not_available

Molecular Weight

463.56

Hydrogen Bond Acceptors Count

5.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

11.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

5.618

Distribution Coefficient, logD

5.618

Water Solubility, LogSw

-5.29

Polar Surface Area

62.305

Acid Dissociation Constant (pKa)

12.17

Base Dissociation Constant (pKb)

2.39

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

34.60

V019-3602 in Drug Discovery

Included in Screening Libraries

Macl-GPIb alpha Interaction Library (22969 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Hemic and lymphatic
  • Cardiovascular

References: we are preparing a list of scientific research reports with V019-3602 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V019-3602?
Check Price and Availability of V019-3602, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V019-3602 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V019-3602
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V019-3602
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V019-3602 available by request